Postnatal Dexamethasone for Bronchopulmonary Dysplasia
- 1 February 2002
- journal article
- Published by American Academy of Pediatrics (AAP) in NeoReviews
- Vol. 3 (2) , e24-e34
- https://doi.org/10.1542/neo.3-2-e24
Abstract
No abstract availableThis publication has 53 references indexed in Scilit:
- Effect of pulse dexamethasone therapy on the incidence and severity of chronic lung disease in the very low birth weight infantThe Journal of Pediatrics, 1995
- Dexamethasone treatment in preterm infants at risk for bronchopulmonary dysplasia.Archives of Disease in Childhood, 1993
- Effects of dexamethasone on the hypothalamic-pituitary-adrenal axis in preterm infantsThe Journal of Pediatrics, 1992
- Hypertrophic cardiomyopathy associated with dexamethasone therapy for bronchopulmonary dysplasiaThe Journal of Pediatrics, 1992
- Prenatal and postnatal corticosteroid therapy to prevent neonatal necrotizing enterocolitis: a controlled trialThe Journal of Pediatrics, 1990
- Adrenal response in very low birthweight babies after dexamethasone treatment for bronchopulmonary dysplasia.Archives of Disease in Childhood, 1989
- Dexamethasone therapy for chronic lung disease in ventilator- and oxygen-dependent infants: A controlled trialThe Journal of Pediatrics, 1989
- A Controlled Trial of Dexamethasone in Preterm Infants at High Risk for Bronchopulmonary DysplasiaNew England Journal of Medicine, 1989
- A randomized, placebo-controlled trial of effects of dexamethasone on hypothalamic-pituitary-adrenal axis in preterm infantsThe Journal of Pediatrics, 1988
- Adrenocortical responsiveness in neonates weaned from the ventilator with dexamethasoneJournal of Paediatrics and Child Health, 1987